Sumatriptan Succinate And Naproxen Sodium Tablet Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Sumatriptan Succinate And Naproxen Sodium Tablet is safe in breast-feeding or not.

What is Sumatriptan Succinate And Naproxen Sodium Tablet used for?


Sumatriptan and Naproxen Sodium Tablets are indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older. Sumatriptan and Naproxen Sodium Tablets are a combination of sumatriptan, a serotonin (5-HT) 1b/1d receptor agonist (triptan), and naproxen sodium, a non-steroidal anti-inflammatory drug, indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older. (1) Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. (1) Not indicated for the prophylactic therapy of migraine attacks. (1) Not indicated for the treatment of cluster headache. (1) Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with Sumatriptan and Naproxen Sodium Tablets, reconsider the diagnosis of migraine before Sumatriptan and Naproxen Sodium Tablets are administered to treat any subsequent attacks. Sumatriptan and Naproxen Sodium Tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of Sumatriptan and Naproxen Sodium Tablets have not been established for cluster headache.

Is using Sumatriptan Succinate And Naproxen Sodium Tablet unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Sumatriptan Succinate And Naproxen Sodium Tablet low risk for breastfeeding
Sumatriptan and Naproxen sodium are the two main ingredients of Sumatriptan Succinate And Naproxen Sodium Tablet. Based on our individual analysis of Sumatriptan and Naproxen sodium we can safely say that Sumatriptan Succinate And Naproxen Sodium Tablet has low risk while breastfeeding. Below we have summarized the usage of Sumatriptan and Naproxen sodium while breastfeeding, we recommend you to go through it for better understanding of your usage.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Both active components of Sumatriptan and Naproxen Sodium Tablets, sumatriptan and naproxen, have been reported to be secreted in human milk. Because of the potential for serious adverse reactions in nursing infants from Sumatriptan and Naproxen Sodium Tablets, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Sumatriptan Succinate And Naproxen Sodium Tablet Breastfeeding Analsys


Sumatriptan while Breastfeeding

Safe

CAS Number: 103628-46-2

Until more information on other Triptan-related compounds are available Sumatriptan is thought to be the safest one because of both a low excretion into breast milk and a low gut absorption.

Naproxen sodium while Breastfeeding

Low Risk

CAS Number: 22204-53-1

Low excreted into breast milk. However, somnolence in 10% of breastfed infants has been reported. A case of acute anemia due to hemorrhage by coagulation disturbance in an one.week aged infant. A competitive effect on liver metabolism has been shown. Long-term use while breastfeeding or in case of newborn jaundice is not recommended. Short-term or sporadic use has a low risk. The American Academy of Pediatrics rates it usually compatible with breastfeeding.


Sumatriptan Succinate And Naproxen Sodium Tablet Breastfeeding Analsys - 2


Sumatriptan while Breastfeeding

CAS Number: 103628-46-2

BBecause of the low levels of sumatriptan in breastmilk, amounts ingested by the infant are small. It also has poor oral bioavailability, further decreasing infant exposure to the drug. Some authors have suggested that withholding breastfeeding for 8 hours after a single subcutaneous injection would virtually eliminate infant exposure to the drug.[1] The manufacturer recommends withholding breastfeeding for 12 hours after a dose. Withholding breastfeeding might be helpful in extreme cases, such as in the mother of a preterm infant, but sumatriptan would not be expected to cause any adverse effects in most breastfed infants. One anecdotal report of lactation ceasing after a single injection of sumatriptan has not been verified.

Naproxen sodium while Breastfeeding

CAS Number: 22204-53-1

Limited information indicates that levels of naproxen in breastmilk are low and adverse effects in breastfed infants are apparently uncommon. However, because of naproxen's long half-life and reported serious adverse reaction in a breastfed neonate, other agents may be preferred while nursing a newborn or preterm infant.



I am nursing mother and I have already used Sumatriptan Succinate And Naproxen Sodium Tablet, what should I do?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Sumatriptan Succinate And Naproxen Sodium Tablet then you shall inform your doctor, But you should not be worried too much as Sumatriptan Succinate And Naproxen Sodium Tablet comes in category of low risk drug.


My health care provider has asked me to use Sumatriptan Succinate And Naproxen Sodium Tablet, what to do?

Though Sumatriptan Succinate And Naproxen Sodium Tablet dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Sumatriptan Succinate And Naproxen Sodium Tablet, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Sumatriptan Succinate And Naproxen Sodium Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week